Chat on WhatsApp

Waiting for the Wegovy pill? Be first to know when it launches in Ireland.

Wegovy weight loss pills

Wegovy weight loss pills

The Wegovy pill (semaglutide) is a daily oral medication for adults working to lose weight. It is designed for people with BMIs over 30, or 27 if they have pre-existing weight-related health conditions. The European Commission approved it for weight management on 15 July 2026, but it is not yet available in Irish pharmacies.

Clinical trials have shown that people on Wegovy can lose up to 17.4% of their body weight.

An overview of the Wegovy pill

While injectable treatments like Mounjaro and Wegovy have dominated the conversation around medical weight loss in Ireland, a significant shift is underway. The Wegovy pill - an oral version of semaglutide - received full EU marketing authorisation from the European Commission on 15 July 2026. It is the first oral GLP-1 medication approved for weight management in the EU.
The Wegovy pill contains the same active ingredient as the injection: semaglutide. It is a GLP-1 receptor agonist that mimics a natural hormone in your body to regulate appetite and slow down digestion, helping you feel fuller for longer.
While an oral version of semaglutide (Rybelsus) has been available in Ireland for years to treat type 2 diabetes, it is only licensed at doses up to 14mg. The Wegovy pill for weight loss uses a maintenance dose of 25mg to achieve results comparable to the 2.4mg weekly injection.
Important: EU approval does not mean the pill is on Irish pharmacy shelves yet. As of August 2026, Novo Nordisk has not confirmed an Irish launch date or Irish pricing. Read our guides: what EU approval means for Irish patients and the full Ireland availability guide.

Who's eligible for the Wegovy pill in Ireland?

Usually, you'll be considered eligible for the Wegovy pill if you meet one of the following two Body Mass Index (BMI) thresholds:
BMI of 30 or higher: This is the standard "obesity" category where medical intervention is typically recommended alongside lifestyle changes.
BMI of 27 to 29.9: You can qualify at this lower threshold if you have at least one weight-related health condition, such as: High blood pressure (hypertension), Type 2 diabetes or pre-diabetes, High cholesterol, Obstructive sleep apnoea, or Cardiovascular disease.
You should always confirm this with your doctor.

How Wegovy weight loss pills work

Data from the OASIS clinical trial programme has shown that the pill is remarkably effective. In the OASIS 1 trial, adults with obesity or overweight who took the 50mg daily pill lost an average of 15.1% to 17.4% of their body weight over 68 weeks.
These results essentially match the "gold standard" set by the Wegovy injection. The trials also confirmed that the safety profile is consistent across both forms; the most common side effects remain gastrointestinal (such as nausea or heart burn), which usually ease as the body adapts to the medication.

Key differences between Wegovy injection and pill

FeatureWegovy InjectionWegovy Pill (Oral)
FrequencyOnce WeeklyOnce Daily
AdministrationSubcutaneous InjectionOral Pill (on empty stomach)
Active IngredientSemaglutideSemaglutide
StorageNeeds refrigerationRoom temperature
Dose (Maintenance)2.4mg25mg

When will the Wegovy weight loss pill be available in Ireland?

The Wegovy pill is now EU-approved (15 July 2026), but Irish patients still cannot collect it from a pharmacy. Here is the current picture as of August 2026.
  • EU status: The European Commission granted marketing authorisation on 15 July 2026, following a positive CHMP opinion on 21 May 2026. Ireland is covered by this central authorisation.
  • Irish availability: The product is not yet stocked in Irish pharmacies. Novo Nordisk must complete commercial launch steps (supply, labelling, wholesaler stocking, and Irish pricing) before prescribing can begin in practice.
  • Realistic window: Late 2026 at the earliest, more likely early 2027, with private prescription access expected before any HSE reimbursement.
  • What you can do now: Injectable Wegovy and Mounjaro are available in Ireland today on private prescription after clinical assessment. Be wary of any website claiming to sell Wegovy pills for Ireland right now.

How much does the Wegovy pill cost in Ireland?

It is too early to give exact pricing for the Irish market. However, in other regions where oral semaglutide is used, the cost is often comparable to the injectable version. It is important to note that, like the injection, the Wegovy pill is expected to be available via private prescription only and is not currently slated for reimbursement under the Long-Term Illness (LTI) or Drug Payment Scheme (DPS) for weight loss in Ireland.

Common Questions

Official Resources

To stay updated on the legal status of medications in Ireland, we recommend following these official bodies:

The Bua Knowledge CentreLightbulb icon

Do I Qualify for Wegovy in Ireland? BMI Criteria, Costs & Eligibility Explained (2026)

Do I Qualify for Wegovy in Ireland? BMI Criteria, Costs & Eligibility Explained (2026)

A practical guide to Wegovy eligibility in Ireland in 2026: BMI criteria, qualifying conditions, contraindications, expected costs, dose schedule, and what happens if you stop.

Read
The Wegovy Pill in Ireland: EU Approved, But When Will You Actually Get It?

The Wegovy Pill in Ireland: EU Approved, But When Will You Actually Get It?

The Wegovy pill is EU-approved as of July 2026, but Irish patients still can't get it. Here's what's left and what you can do now.

Read
Is Wegovy Safe? Side Effects, Risks and What Irish Patients Need to Know Before Starting

Is Wegovy Safe? Side Effects, Risks and What Irish Patients Need to Know Before Starting

Thinking about starting Wegovy in Ireland? This guide covers common side effects, serious risks, who should not take it, and what to expect before you begin.

Read
Wegovy vs Mounjaro in Ireland: Which Weight Loss Injection Is Right for You? (2026)

Wegovy vs Mounjaro in Ireland: Which Weight Loss Injection Is Right for You? (2026)

An evidence-based comparison of Wegovy and Mounjaro in Ireland: mechanism, weight-loss outcomes, side effects, access, cost, and who each treatment may suit best.

Read
What Happens When You Stop Taking Wegovy? Weight Regain, Tapering and Long-Term Management

What Happens When You Stop Taking Wegovy? Weight Regain, Tapering and Long-Term Management

A practical guide to what happens after stopping Wegovy: weight regain timelines, tapering approaches, and long-term management strategies for Irish patients.

Read
Can My GP Prescribe Wegovy in Ireland? A 2026 Guide

Can My GP Prescribe Wegovy in Ireland? A 2026 Guide

Yes, your GP can prescribe Wegovy in Ireland - but practical access, follow-up structure, and ongoing support can vary significantly in real-world care.

Read
The Wegovy Pill Is Now EU-Approved: What It Means for Irish Patients

The Wegovy Pill Is Now EU-Approved: What It Means for Irish Patients

The EU approved the Wegovy pill on 15 July 2026. What Irish patients need to know about availability, eligibility, and what to do now.

Read
View all blog posts